My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1055

    1.

    Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: longitudinal change in comparison to healthy individuals.

    Rapeli P, Fabritius C, Kalska H, Alho H.

    Subst Abuse Treat Prev Policy. 2009 Apr 17;4:6.PMID: 19374740 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.

    Rapeli P, Fabritius C, Alho H, Salaspuro M, Wahlbeck K, Kalska H.

    BMC Clin Pharmacol. 2007 Jun 12;7:5.PMID: 17565668 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.

    Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D.

    Addiction. 2007 Apr;102(4):616-22. Epub 2007 Feb 6.PMID: 17286641 [PubMed - indexed for MEDLINE]Related articles

    4.

    Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.

    Giacomuzzi S, Kemmler G, Ertl M, Riemer Y.

    Subst Use Misuse. 2006;41(2):223-44.PMID: 16393744 [PubMed - indexed for MEDLINE]Related articles

    5.

    Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.

    Seifert J, Metzner C, Paetzold W, Borsutzky M, Passie T, Rollnik J, Wiese B, Emrich HM, Schneider U.

    Pharmacopsychiatry. 2002 Sep;35(5):159-64.PMID: 12237786 [PubMed - indexed for MEDLINE]Related articles

    6.

    Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial.

    Soyka M, Lieb M, Kagerer S, Zingg C, Koller G, Lehnert P, Limmer C, Kuefner H, Hennig-Fast K.

    J Clin Psychopharmacol. 2008 Dec;28(6):699-703.PMID: 19011441 [PubMed - indexed for MEDLINE]Related articles

    7.

    Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.

    [No authors listed]

    Prescrire Int. 2007 Dec;16(92):232-5.PMID: 18087797 [PubMed - indexed for MEDLINE]Related articles

    8.

    A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

    Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE.

    N Engl J Med. 2000 Nov 2;343(18):1290-7.PMID: 11058673 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.

    Loeber S, Kniest A, Diehl A, Mann K, Croissant B.

    Am J Drug Alcohol Abuse. 2008;34(5):584-93.PMID: 18720267 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.

    Winstock AR, Lea T, Sheridan J.

    Int J Drug Policy. 2008 Dec;19(6):450-8. Epub 2008 Mar 21.PMID: 18359216 [PubMed - indexed for MEDLINE]Related articles

    11.

    QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.

    Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC.

    Arch Intern Med. 2007 Dec 10;167(22):2469-75.PMID: 18071169 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment.

    Giacomuzzi SM, Ertl M, Kemmler G, Riemer Y, Vigl A.

    ScientificWorldJournal. 2005 May 24;5:452-68.PMID: 15925962 [PubMed - indexed for MEDLINE]Related articles

    13.

    Comparison of buprenorphine and methadone in the treatment of opioid dependence.

    Strain EC, Stitzer ML, Liebson IA, Bigelow GE.

    Am J Psychiatry. 1994 Jul;151(7):1025-30.PMID: 8010359 [PubMed - indexed for MEDLINE]Related articles

    14.

    Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?

    Reed LJ, Glasper A, de Wet CJ, Bearn J, Gossop M.

    J Clin Psychopharmacol. 2007 Apr;27(2):188-92.PMID: 17414244 [PubMed - indexed for MEDLINE]Related articles

    15.

    Opioid dependence treatment, including buprenorphine/naloxone.

    Raisch DW, Fye CL, Boardman KD, Sather MR.

    Ann Pharmacother. 2002 Feb;36(2):312-21. Review.PMID: 11847954 [PubMed - indexed for MEDLINE]Related articles

    16.

    Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation.

    Degenhardt L, Larance BK, Bell JR, Winstock AR, Lintzeris N, Ali RL, Scheuer N, Mattick RP.

    Med J Aust. 2009 Aug 3;191(3):161-5.PMID: 19645647 [PubMed - indexed for MEDLINE]Related articles

    17.

    Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users.

    Strain EC, Stitzer ML, Liebson IA, Bigelow GE.

    Psychopharmacology (Berl). 1994 Dec;116(4):401-6.PMID: 7701040 [PubMed - indexed for MEDLINE]Related articles

    18.

    Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.

    Lavie E, Fatséas M, Denis C, Auriacombe M.

    Drug Alcohol Depend. 2009 Jan 1;99(1-3):338-44. Epub 2008 Sep 27.PMID: 18824311 [PubMed - indexed for MEDLINE]Related articles

    19.

    Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients.

    Lintzeris N, Mitchell TB, Bond AJ, Nestor L, Strang J.

    Drug Alcohol Depend. 2007 Dec 1;91(2-3):187-94. Epub 2007 Jul 12.PMID: 17624687 [PubMed - indexed for MEDLINE]Related articles

    20.

    A pilot study about the feasibility and cost-effectiveness of electronic compliance monitoring in substitution treatment with buprenorphine-naloxone combination.

    Tacke U, Uosukainen H, Kananen M, Kontra K, Pentikänen H.

    J Opioid Manag. 2009 Nov-Dec;5(6):321-9.PMID: 20073406 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk